Donita Jones
Psychiatric/Mental Health · Jacksonville, FLNPI 1326577545
Payments from drug & device makers
Across 424 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$1K
- Vanda Pharmaceuticals Inc.$1K
- Axsome Therapeutics, Inc.$707
- Takeda Pharmaceuticals U.S.A., Inc.$604
- plus $3K from 19 others
What the payments were for
- Food & beverage$9,74399%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 87 | $1,618 |
| Teva Pharmaceuticals USA, Inc. | 84 | $1,517 |
| Johnson & Johnson | 44 | $1,204 |
| Vanda Pharmaceuticals Inc. | 37 | $1,028 |
| Axsome Therapeutics, Inc. | 17 | $707 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $604 |
| Otsuka America Pharmaceutical, Inc. | 24 | $596 |
| Alkermes, Inc. | 21 | $542 |
| Neurocrine Biosciences, Inc. | 7 | $253 |
| E.r. Squibb & Sons, L.L.C. | 6 | $220 |
| Lundbeck LLC | 11 | $217 |
| Almatica Pharma LLC | 9 | $183 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $176 |
| Eisai Inc. | 3 | $144 |
| Banner Life Sciences, LLC | 10 | $133 |
| Tris Pharma Inc | 1 | $124 |
| Indivior Inc. | 6 | $122 |
| Idorsia Pharmaceuticals US Inc | 6 | $119 |
| Merck | 6 | $100 |
| Avanir Pharmaceuticals, Inc. | 5 | $91 |
| Bausch Health US, LLC | 4 | $77 |
| Corium, LLC | 1 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
- Auvelity$332
- INVEGA SUSTENNA$279
- VRAYLAR$225
- SPRAVATO$140
- Quillivant$124
- Dyanavel XR$124
- Quillichew ER$124
- INGREZZA$123
- COBENFY$120
- UZEDY$116
- ABILIFY MAINTENA$115
- Fanapt$115
- Dayvigo$113
How this compares
$9,841 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 20 | $30,661 |
| CaplytaLumateperone Tosylate | 12 | $22,684 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $1,121 |
| Aripiprazole | 38 | $1,010 |
| Temazepam | 29 | $974 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $634 |
| Quetiapine Fumarate | 63 | $578 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 17 | $577 |
| Risperidone | 32 | $499 |
| Benztropine Mesylate | 32 | $483 |
| Hydroxyzine Pamoate | 35 | $464 |
| Clonazepam | 66 | $453 |
| Mirtazapine | 23 | $337 |
| Trazodone Hcl | 69 | $319 |
| Buspirone Hcl | 22 | $300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,618 | $30,66120 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $176 | $22,68412 claims |
| Almatica Pharma LLCSertraline Hcl | $183 | $28666 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Jacksonville
- Bethanie Simmons BecilJacksonville$782K
- Karen McNeelyJacksonville$13K
- Roger RiveraKissimmee$1.6M
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.